...
首页> 外文期刊>Egyptian Pediatric Association Gazette >Seroprevalence of parvovirus B19 infection in patients with beta thalassemia major in Fayoum University Hospital
【24h】

Seroprevalence of parvovirus B19 infection in patients with beta thalassemia major in Fayoum University Hospital

机译:法尤姆大学医院严重β地中海贫血患者细小病毒B19感染的血清阳性率

获取原文

摘要

Background and objectives Patients with beta thalassemia major are at higher risk of acquiring reticulocytopenia, and cessation of erythropoiesis after exposure to parvovirus B19. The aim of the study was to detect the seroprevalence of parvovirus B19 infection in children with transfusion dependent beta-thalassemia major through the detection of its specific IgM and IgG in their sera by Enzyme-linked Immunosorbent Assay (ELISA) in the Pediatric Department of Fayoum University Hospital. Materials and methods A cross sectional descriptive study was carried out from July to September 2013, in the Pediatric Department of Fayoum University Hospital in Egypt. A total of fifty-five children with beta-thalassemia major aged from 2 to 16 years were enrolled in the study. All patients were subjected to history taking, examination and investigations including; Complete blood count, serum creatinine, blood urea, hepatitis B surface antigen (HBsAg), anti hepatitis C virus antibody (anti HCV), reticulocytic count, anti B19 IgM and IgG. Results Anti-B19 IgM antibodies (recent infection) were detected in 14.5% (8 patients), while anti B19 IgG antibodies (prior infection) were detected in 18.2% (10 patients) of transfusion dependent thalassemic patients. There was a significant statistical correlation between the history of other siblings with beta thalassemia major, the hepatitis C virus and hepatitis B virus infection regarding absent, prior and recent infection. Conclusion Parvovirus B19 infection is detected in high rates among children with beta thalassemia major. Measures to avoid iatrogenic and nosocomial transmission have to be implemented including screening of donated blood for B19 especially blood given to patients with hematological disorders. Also data from this study support the need for introduction of an approved B19 vaccine that primarily protects children with thalassemia major against that infection.
机译:背景与目标重度β地中海贫血患者在接触细小病毒B19后,发生网状细胞减少症和停止红细胞生成的风险较高。该研究的目的是通过Fayoum儿科的酶联免疫吸附测定(ELISA)检测其血清中的特异性IgM和IgG,从而检测患有严重输血依赖性β-地中海贫血的儿童中细小病毒B19感染的血清流行率。大学医院。材料和方法2013年7月至9月,在埃及法尤姆大学医院儿科进行了横断面描述性研究。该研究共纳入55名2至16岁的重度β地中海贫血儿童。所有患者均接受了历史记录,检查和调查,包括:全血细胞计数,血清肌酐,血尿素,乙型肝炎表面抗原(HBsAg),抗丙型肝炎病毒抗体(抗HCV),网状细胞计数,抗B19 IgM和IgG。结果在依赖输血的地中海贫血患者中检测到14.5%(8例患者)的抗B19 IgM抗体(近期感染),而在18.2%(10例患者)中检测到抗B19 IgG抗体(先前感染)。在其他β-地中海贫血兄弟姐妹,丙型肝炎病毒和乙型肝炎病毒感染的其他兄弟姐妹的病史中,无,先前和近期感染均存在显着的统计学相关性。结论在重型β地中海贫血患儿中细小病毒B19感染率很高。必须采取避免医源性和医院传播的措施,包括筛查捐赠的血液中的B19,尤其是血液病患者的血液。该研究的数据还支持需要引入批准的B19疫苗,该疫苗主要保护重症地中海贫血儿童免受这种感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号